{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:32:59Z","timestamp":1794562379180,"version":"4.9.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C507\/A27657,C9545\/A29580,SEBINT-2024\/100003,C1287\/A26886,EDDRPG-May24\/100002 & C36857\/A27548"],"award-info":[{"award-number":["C507\/A27657,C9545\/A29580,SEBINT-2024\/100003,C1287\/A26886,EDDRPG-May24\/100002 & C36857\/A27548"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018956","name":"NIHR | NIHR Cambridge Biomedical Research Centre","doi-asserted-by":"publisher","award":["BRC-1215-20014"],"award-info":[{"award-number":["BRC-1215-20014"]}],"id":[{"id":"10.13039\/501100018956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018956","name":"NIHR | NIHR Cambridge Biomedical Research Centre","doi-asserted-by":"publisher","award":["NIHR203312"],"award-info":[{"award-number":["NIHR203312"]}],"id":[{"id":"10.13039\/501100018956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014599","name":"Mark Foundation For Cancer Research","doi-asserted-by":"publisher","award":["RG95043"],"award-info":[{"award-number":["RG95043"]}],"id":[{"id":"10.13039\/100014599","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022011","name":"cambridgeuniversity | Cancer Research UK Cambridge Institute, University of Cambridge","doi-asserted-by":"publisher","award":["C9685\/A25177"],"award-info":[{"award-number":["C9685\/A25177"]}],"id":[{"id":"10.13039\/501100022011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022011","name":"cambridgeuniversity | Cancer Research UK Cambridge Institute, University of Cambridge","doi-asserted-by":"publisher","award":["CTRQQR- 2021\\100012"],"award-info":[{"award-number":["CTRQQR- 2021\\100012"]}],"id":[{"id":"10.13039\/501100022011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002927","name":"CUH | Addenbrooke's Charitable Trust, Cambridge University Hospitals","doi-asserted-by":"publisher","award":["ACT 9800"],"award-info":[{"award-number":["ACT 9800"]}],"id":[{"id":"10.13039\/501100002927","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CRUK City of London Major Centre Awards","award":["C7893\/A26233 and CTRQQR-2021\\100004"],"award-info":[{"award-number":["C7893\/A26233 and CTRQQR-2021\\100004"]}]},{"name":"CRUK-Royal College of Surgeons of England Clinician Scientist Fellowship","award":["C64667\/A27958"],"award-info":[{"award-number":["C64667\/A27958"]}]},{"name":"Breast Cancer Now Toby Robins Research Centre","award":["CTR-Q5-Y3"],"award-info":[{"award-number":["CTR-Q5-Y3"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Methods to detect circulating tumor DNA (ctDNA) enable minimally invasive responsive monitoring of cancer dynamics. However, sensitive and cost-effective methods are still lacking. Current methods for detecting cancer signals in shallow whole-genome sequencing (sWGS) data from cell-free DNA (cfDNA) via copy number aberration (CNA) analysis typically have a limit of detection of approximately 3% tumor fraction (TF). We developed informCNA, a bioinformatics method that leverages CNA information from sWGS of tumor or pre-treatment plasma samples with high TF as references, enabling ctDNA detection down to 0.2% TF across multiple cancer types. In 177 serial plasma samples from 18 patients with ovarian cancer, informCNA showed high concordance with the standard serum protein marker CA-125 and identified recurrence a median of 3.7 months earlier than CA-125 test. These results demonstrate the potential of personalized CNA analysis through sWGS for estimating ctDNA burden, enabling precise and cost-effective disease monitoring and early detection of relapse.<\/jats:p>","DOI":"10.1038\/s44321-026-00399-4","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T09:47:27Z","timestamp":1773913647000},"page":"1429-1455","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["ctDNA monitoring using tumor-informed copy number analysis"],"prefix":"10.1038","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4522-182X","authenticated-orcid":false,"given":"Ze","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ros","family":"Cutts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Hrebien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina X","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Garcia\u2011Murillas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woody Z","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander M","family":"Frankell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3416-9982","authenticated-orcid":false,"given":"Wendy N","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2034-2759","authenticated-orcid":false,"given":"Amit","family":"Roshan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas C","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1892-5461","authenticated-orcid":false,"given":"Tommy","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2825-4788","authenticated-orcid":false,"given":"Nitzan","family":"Rosenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2818-2911","authenticated-orcid":false,"given":"Hui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"399_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00965-y","volume":"8","author":"VA Adalsteinsson","year":"2017","unstructured":"Adalsteinsson VA, Ha G, Freeman SS, Choudhury AD, Stover DG, Parsons HA, Gydush G, Reed SC, Rotem D, Rhoades J et al (2017) Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors. Nat Commun 8:1324","journal-title":"Nat Commun"},{"key":"399_CR2","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1158\/0008-5472.CAN-16-1553","volume":"77","author":"N Andor","year":"2017","unstructured":"Andor N, Maley CC, Ji HP (2017) Genomic instability in cancer: teetering on the limit of tolerance. Cancer Res 77:2179\u20132185","journal-title":"Cancer Res"},{"key":"399_CR3","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/s41588-023-01376-0","volume":"55","author":"JH Bae","year":"2023","unstructured":"Bae JH, Liu R, Roberts E, Nguyen E, Tabrizi S, Rhoades J, Blewett T, Xiong K, Gydush G, Shea D et al (2023) Single duplex DNA sequencing with CODEC detects mutations with high sensitivity. Nat Genet 55:871\u2013879","journal-title":"Nat Genet"},{"key":"399_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-025-00876-y","volume":"9","author":"A Bartolomucci","year":"2025","unstructured":"Bartolomucci A, Nobrega M, Ferrier T, Dickinson K, Kaorey N, Nadeau A, Castillo A, Burnier JV (2025) Circulating tumor DNA to monitor treatment response in solid tumors and advance precision oncology. NPJ Precis Oncol 9:84","journal-title":"NPJ Precis Oncol"},{"key":"399_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51577-2","volume":"15","author":"S Basyuni","year":"2024","unstructured":"Basyuni S, Heskin L, Degasperi A, Black D, Koh GCC, Chmelova L, Rinaldi G, Bell S, Grybowicz L, Elgar G et al (2024) Large-scale analysis of whole genome sequencing data from formalin-fixed paraffin-embedded cancer specimens demonstrates preservation of clinical utility. Nat Commun 15:7731","journal-title":"Nat Commun"},{"key":"399_CR6","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/nature08822","volume":"463","author":"R Beroukhim","year":"2010","unstructured":"Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, Donovan J, Barretina J, Boehm JS, Dobson J, Urashima M et al (2010) The landscape of somatic copy-number alteration across human cancers. Nature 463:899\u2013905","journal-title":"Nature"},{"key":"399_CR7","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41591-024-03216-y","volume":"31","author":"JRM Black","year":"2025","unstructured":"Black JRM, Bartha G, Abbott CW, Boyle SM, Karasaki T, Li B, Chen R, Harris J, Veeriah S, Colopi M et al (2025a) Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma. Nat Med 31:70\u201376","journal-title":"Nat Med"},{"key":"399_CR8","doi-asserted-by":"crossref","unstructured":"Black JRM, Karasaki T, Abbott CW, Li B, Veeriah S, Al Bakir M, Liu WK, Huebner A, Mart\u00ednez-Ruiz C, Pawlik P et al (2025b) Longitudinal ultrasensitive ctDNA monitoring for high-resolution lung cancer risk prediction. Cell 188:7083\u20137098","DOI":"10.1016\/j.cell.2025.10.020"},{"key":"399_CR9","doi-asserted-by":"crossref","unstructured":"Ch\u00e9n OY, Bodelet JS, Saraiva RG, Phan H, Di J, Nagels G, Schwantje T, Cao H, Gou J, Reinen JM et al (2023) The roles, challenges, and merits of the p value. Patterns 4:100878","DOI":"10.1016\/j.patter.2023.100878"},{"key":"399_CR10","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1038\/s41587-021-00900-z","volume":"39","author":"JD Cohen","year":"2021","unstructured":"Cohen JD, Douville C, Dudley JC, Mog BJ, Popoli M, Ptak J, Dobbyn L, Silliman N, Schaefer J, Tie J et al (2021) Detection of low-frequency DNA variants by targeted sequencing of the Watson and Crick strands. Nat Biotechnol 39:1220\u20131227","journal-title":"Nat Biotechnol"},{"key":"399_CR11","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1158\/1078-0432.CCR-24-3472","volume":"31","author":"MJ Elliott","year":"2025","unstructured":"Elliott MJ, Howarth K, Main S, Fuentes Antra\u0301s J, Echelard P, Dou A, Amir E, Nadler MB, Shah E, Yu C et al (2025) Ultrasensitive detection and monitoring of circulating tumor DNA using structural variants in early-stage breast cancer. Clin Cancer Res 31:1520\u20131532","journal-title":"Clin Cancer Res"},{"key":"399_CR12","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.annonc.2022.02.007","volume":"33","author":"D Gale","year":"2022","unstructured":"Gale D, Heider K, Ruiz-Valdepenas A, Hackinger S, Perry M, Marsico G, Rundell V, Wulff J, Sharma G, Knock H et al (2022) Residual ctDNA after treatment predicts early relapse in patients with early-stage non-small cell lung cancer. Ann Oncol 33:500\u2013510","journal-title":"Ann Oncol"},{"key":"399_CR13","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","volume":"569","author":"M Ghandi","year":"2019","unstructured":"Ghandi M, Huang FW, Jan\u00e9-Valbuena J, Kryukov GV, Lo CC, McDonald ER, Barretina J, Gelfand ET, Bielski CM, Li H et al (2019) Next-generation characterization of the Cancer Cell Line Encyclopedia. Nature 569:503\u2013508","journal-title":"Nature"},{"key":"399_CR14","doi-asserted-by":"crossref","unstructured":"Gupta D, Lis CG (2009) Role of CA125 in predicting ovarian cancer survival\u2014a review of the epidemiological literature. J Ovarian Res 2:13","DOI":"10.1186\/1757-2215-2-13"},{"key":"399_CR15","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.ejso.2021.11.138","volume":"48","author":"P Kirchweger","year":"2022","unstructured":"Kirchweger P, Kupferthaler A, Burghofer J, Webersinke G, Jukic E, Schwendinger S, Weitzendorfer M, Petzer A, F\u00fcgger R, Rumpold H et al (2022) Circulating tumor DNA correlates with tumor burden and predicts outcome in pancreatic cancer irrespective of tumor stage. Eur J Surg Oncol 48:1046\u20131053","journal-title":"Eur J Surg Oncol"},{"key":"399_CR16","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41586-024-08129-x","volume":"636","author":"Y Lin","year":"2024","unstructured":"Lin Y, Wang J, Wang K, Bai S, Thennavan A, Wei R, Yan Y, Li J, Elgamal H, Sei E et al (2024) Normal breast tissues harbour rare populations of aneuploid epithelial cells. Nature 636:663\u2013670","journal-title":"Nature"},{"key":"399_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2011-12-4-r41","volume":"12","author":"CH Mermel","year":"2011","unstructured":"Mermel CH, Schumacher SE, Hill B, Meyerson ML, Beroukhim R, Getz G (2011) GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol 12:R41","journal-title":"Genome Biol"},{"key":"399_CR18","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1158\/2159-8290.CD-21-0634","volume":"11","author":"EJ Moding","year":"2021","unstructured":"Moding EJ, Nabet BY, Alizadeh AA, Diehn M (2021) Detecting liquid remnants of solid tumors: circulating tumor DNA minimal residual disease. Cancer Discov 11:2968\u20132986","journal-title":"Cancer Discov"},{"key":"399_CR19","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aat4921","volume":"10","author":"F Mouliere","year":"2018","unstructured":"Mouliere F, Chandrananda D, Piskorz AM, Moore EK, Morris J, Ahlborn LB, Mair R, Goranova T, Marass F, Heider K et al (2018) Enhanced detection of circulating tumor DNA by fragment size analysis. Sci Transl Med 10:eaat4921","journal-title":"Sci Transl Med"},{"key":"399_CR20","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/nm.3519","volume":"20","author":"AM Newman","year":"2014","unstructured":"Newman AM, Bratman SV, To J, Wynne JF, Eclov NCW, Modlin LA, Liu CL, Neal JW, Wakelee HA, Merritt RE et al (2014) An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. Nat Med 20:548\u2013554","journal-title":"Nat Med"},{"key":"399_CR21","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nbt.3520","volume":"34","author":"AM Newman","year":"2016","unstructured":"Newman AM, Lovejoy AF, Klass DM, Kurtz DM, Chabon JJ, Scherer F, Stehr H, Liu CL, Bratman SV, Say C et al (2016) Integrated digital error suppression for improved detection of circulating tumor DNA. Nat Biotechnol 34:547\u2013555","journal-title":"Nat Biotechnol"},{"key":"399_CR22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41571-024-00967-y","volume":"22","author":"K Pantel","year":"2025","unstructured":"Pantel K, Alix-Panabi\u00e8res C (2025) Minimal residual disease as a target for liquid biopsy in patients with solid tumours. Nat Rev Clin Oncol 22:65\u201377","journal-title":"Nat Rev Clin Oncol"},{"key":"399_CR23","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1158\/1078-0432.CCR-20-3345","volume":"27","author":"L Paracchini","year":"2021","unstructured":"Paracchini L, Beltrame L, Grassi T, Inglesi A, Fruscio R, Landoni F, Ippolito D, Delle Marchette M, Paderno M, Adorni M et al (2021) Genome-wide copy-number alterations in circulating tumor DNA as a novel biomarker for patients with high-grade serous ovarian cancer. Clin Cancer Res 27:2549\u20132559","journal-title":"Clin Cancer Res"},{"key":"399_CR24","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1158\/1078-0432.CCR-18-4044","volume":"26","author":"A Pearson","year":"2020","unstructured":"Pearson A, Proszek P, Pascual J, Fribbens C, Shamsher MK, Kingston B, O\u2019Leary B, Herrera-Abreu MT, Cutts RJ, Garcia-Murillas I et al (2020) Inactivating NF1 mutations are enriched in advanced breast cancer and contribute to endocrine therapy resistance. Clin Cancer Res 26:608\u2013622","journal-title":"Clin Cancer Res"},{"key":"399_CR25","doi-asserted-by":"publisher","first-page":"3687","DOI":"10.1093\/bioinformatics\/btaa222","volume":"36","author":"C Pockrandt","year":"2020","unstructured":"Pockrandt C, Alzamel M, Iliopoulos CS, Reinert K (2020) GenMap: ultra-fast computation of genome mappability. Bioinformatics 36:3687\u20133692","journal-title":"Bioinformatics"},{"key":"399_CR26","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/bioinformatics\/bty1055","volume":"35","author":"JB Poell","year":"2019","unstructured":"Poell JB, Mendeville M, Sie D, Brink A, Brakenhoff RH, Ylstra B (2019) ACE: absolute copy number estimation from low-coverage whole-genome sequencing data. Bioinformatics 35:2847\u20132849","journal-title":"Bioinformatics"},{"key":"399_CR27","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/s41591-021-01411-9","volume":"27","author":"R Saiki","year":"2021","unstructured":"Saiki R, Momozawa Y, Nannya Y, Nakagawa MM, Ochi Y, Yoshizato T, Terao C, Kuroda Y, Shiraishi Y, Chiba K et al (2021) Combined landscape of single-nucleotide variants and copy number alterations in clonal hematopoiesis. Nat Med 27:1239\u20131249","journal-title":"Nat Med"},{"key":"399_CR28","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202216505","volume":"15","author":"A Santonja","year":"2023","unstructured":"Santonja A, Cooper WN, Eldridge MD, Edwards PAW, Morris JA, Edwards AR, Zhao H, Heider K, Couturier D, Vijayaraghavan A et al (2023) Comparison of tumor-informed and tumor-na\u00efve sequencing assays for ctDNA detection in breast cancer. EMBO Mol Med 15:e16505","journal-title":"EMBO Mol Med"},{"key":"399_CR29","doi-asserted-by":"publisher","unstructured":"Sauer CM, Eldridge MD, Vias M, Hall JA, Boyle S, Macintyre G, Bradley T, Markowetz F, Brenton JD (2021) Absolute copy number fitting from shallow whole genome sequencing data. Preprint at https:\/\/doi.org\/10.1101\/2021.07.19.452658","DOI":"10.1101\/2021.07.19.452658"},{"key":"399_CR30","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1126\/science.aaa9119","volume":"349","author":"J Shendure","year":"2015","unstructured":"Shendure J, Akey JM (2015) The origins, determinants, and consequences of human mutations. Science 349:1478\u20131483","journal-title":"Science"},{"key":"399_CR31","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/s41586-022-04738-6","volume":"606","author":"CD Steele","year":"2022","unstructured":"Steele CD, Abbasi A, Islam SMA, Bowes AL, Khandekar A, Haase K, Hames-Fathi S, Ajayi D, Verfaillie A, Dhami P et al (2022) Signatures of copy number alterations in human cancer. Nature 606:984\u2013991","journal-title":"Nature"},{"key":"399_CR43","doi-asserted-by":"crossref","unstructured":"Talevich E, Shain AH, Botton T, Bastian BC (2016) CNVkit: genome-wide copy number detection and visualization from targeted DNA sequencing. PLoS Comput Biol 12(4):e1004873","DOI":"10.1371\/journal.pcbi.1004873"},{"key":"399_CR32","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.ccell.2018.03.007","volume":"33","author":"AM Taylor","year":"2018","unstructured":"Taylor AM, Shih J, Ha G, Gao GF, Zhang X, Berger Ashton C, Schumacher Steven E, Wang C, Hu H, Liu J et al (2018) Genomic and functional approaches to understanding cancer aneuploidy. Cancer Cell 33:676\u2013689.e3","journal-title":"Cancer Cell"},{"key":"399_CR35","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1056\/NEJMoa2200075","volume":"386","author":"J Tie","year":"2022","unstructured":"Tie J, Cohen JD, Lahouel K, Lo SN, Wang Y, Kosmider S, Wong R, Shapiro J, Lee M, Harris S et al (2022) Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer. N Engl J Med 386:2261\u20132272","journal-title":"N Engl J Med"},{"key":"399_CR36","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1093\/annonc\/mdv177","volume":"26","author":"J Tie","year":"2015","unstructured":"Tie J, Kinde I, Wang Y, Wong HL, Roebert J, Christie M, Tacey M, Wong R, Singh M, Karapetis CS et al (2015) Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer. Ann Oncol 26:1715\u20131722","journal-title":"Ann Oncol"},{"key":"399_CR37","doi-asserted-by":"publisher","first-page":"107299","DOI":"10.1016\/j.sigpro.2019.107299","volume":"167","author":"C Truong","year":"2020","unstructured":"Truong C, Oudre L, Vayatis N (2020) Selective review of offline change point detection methods. Signal Process 167:107299","journal-title":"Signal Process"},{"key":"399_CR38","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaz8084","volume":"12","author":"JCM Wan","year":"2020","unstructured":"Wan JCM, Heider K, Gale D, Murphy S, Fisher E, Mouliere F, Ruiz-Valdepenas A, Santonja A, Morris J, Chandrananda D et al (2020) ctDNA monitoring using patient-specific sequencing and integration of variant reads. Sci Transl Med 12:eaaz8084","journal-title":"Sci Transl Med"},{"key":"399_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-025-03607-5","volume":"26","author":"H Wang","year":"2025","unstructured":"Wang H, Mennea PD, Chan YKE, Cheng Z, Neofytou MC, Surani AA, Vijayaraghavan A, Ditter E-J, Bowers R, Eldridge MD et al (2025) A standardized framework for robust fragmentomic feature extraction from cell-free DNA sequencing data. Genome Biol 26:141","journal-title":"Genome Biol"},{"key":"399_CR40","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1038\/s41591-024-03040-4","volume":"30","author":"AJ Widman","year":"2024","unstructured":"Widman AJ, Shah M, Frydendahl A, Halmos D, Khamnei CC, \u00d8gaard N, Rajagopalan S, Arora A, Deshpande A, Hooper WF et al (2024) Ultrasensitive plasma-based monitoring of tumor burden using machine-learning-guided signal enrichment. Nat Med 30:1655\u20131666","journal-title":"Nat Med"},{"key":"399_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-020-01983-8","volume":"21","author":"PA Zhao","year":"2020","unstructured":"Zhao PA, Sasaki T, Gilbert DM (2020) High-resolution Repli-Seq defines the temporal choreography of initiation, elongation and termination of replication in mammalian cells. Genome Biol 21:76","journal-title":"Genome Biol"},{"key":"399_CR42","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1038\/s41591-020-0915-3","volume":"26","author":"A Zviran","year":"2020","unstructured":"Zviran A, Schulman RC, Shah M, Hill STK, Deochand S, Khamnei CC, Maloney D, Patel K, Liao W, Widman AJ et al (2020) Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring. Nat Med 26:1114\u20131124","journal-title":"Nat Med"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00399-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-026-00399-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00399-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:44:32Z","timestamp":1779065072000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-026-00399-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":41,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,15]]}},"alternative-id":["399"],"URL":"https:\/\/doi.org\/10.1038\/s44321-026-00399-4","relation":{},"ISSN":["1757-4684"],"issn-type":[{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]},"assertion":[{"value":"5 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"ZZ, HZ, and NR are co-inventors on a patent application filed by Cancer Research UK based on the data presented in this study, and managed in accordance with institutional policies.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}